 Dr. Bharati Bapat |
October 2016
Dr. Bharati Bapat
Biomarkers for personalized treatment of cancer
Dr. Bapat is a Professor in the Department of Laboratory Medicine and Pathobiology and Department of Surgery (Division of Urology), University of Toronto. She is a Principal Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System.
Dr. Bapat’s research program is focused on the discovery of cancer biomarkers, and understanding their role in cancer development. Using cutting-edge technologies to examine patients’ genomes and also using cells cultured in petri-dishes from patients’ tumor samples, her research team has identified diagnostic and prognostic biomarkers of common malignancies such as prostate, bladder and colon cancer. Dr. Bapat is involved in several national and international collaborative prostate cancer research projects to develop biomarkers for personalized medicine using less invasive strategies to obtain patient samples (urine, blood, biopsy tissue) to minimize patient discomfort. Dr. Bapat envisions the application of these discoveries into clinical practice by utilizing such diagnostic, prognostic and predictive cancer biomarkers to improve patient care.
Dr. Bapat has authored over 100 peer-reviewed publications.
2015: Dr. Daniel Schramek
Principal Investigator, Lunenfeld-Tanenbaum Research Institute
Topic: Personalized Cancer Treatment
2014: Dr. Ian Rogers
Senior Investigator, Lunenfeld-Tanenbaum Research Institute
Topic: Kidney Disease
2013: Dr. Rod Bremner
Senior Scientist, Lunenfeld-Tanenbaum Research Institute
Topic: Finding Strategies to Prevent and Treat Cancer
2012: Dr. James Dennis
Senior Investigator, Samuel Lunenfeld Research Institute
Topic - Sugar-Coating the Cell Surface
2011: Dr. Anne-Claude Gingras
Investigator, Samuel Lunenfeld Research Institute
Topic - Proteomics
2010: Dr. Sabine Cordes
Senior Investigator, Samuel Lunenfeld Research Institute
Topic - Genetics of Mood Disorders
2009: Dr. Robert Casper
Senior Investigator, Samuel Lunenfeld Research Institute
Topic - Inhibition of Cancer Growth by a Stem Cell Factor